Feed LINCOLN.NS
LI
Lincoln Pharmaceuticals Limited
LINCOLN.NS · NSE
₹596.00 -0.08% (-₹0.50)
1M -2.29%
Market Cap ₹11.8B
P/E Ratio 13.69x
Div. Yield -
ROE 13.17%
Bulios Fair Price
₹635.6
6.6% upside
Preț actual
₹596
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile LINCOLN.NS sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
86 /100
Cheap P/B 1.76x
P/S 1.88x
P/E 13.69x
Growth
72 /100
Growing Book val. growth 15.77%
FCF growth 34.08%
EPS growth 5.88%
Profitability
56 /100
Moderate FCF margin 0.00%
Op. margin 14.19%
Gross margin 53.90%
Quality
61 /100
Average ROE 13.17%
ROA N/A
Asset turnover N/A
Debt
100 /100
Low Int. coverage 70.61x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
82 /100
Stable Profitable years 6
EPS volatility 19.93%
Beta 0.37x
Întreabă StockBot despre LINCOLN.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mahendrabhai Gulabdas Patel
Employees
1,687
Headquarters
Ahmedabad